Matches in Wikidata for { <http://www.wikidata.org/entity/Q66061429> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66061429 description "clinical trial" @default.
- Q66061429 description "ensayu clínicu" @default.
- Q66061429 description "klinisch onderzoek" @default.
- Q66061429 description "клінічне випробування" @default.
- Q66061429 name "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria" @default.
- Q66061429 name "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride" @default.
- Q66061429 type Item @default.
- Q66061429 label "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria" @default.
- Q66061429 label "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride" @default.
- Q66061429 prefLabel "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria" @default.
- Q66061429 prefLabel "A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride" @default.
- Q66061429 P1050 Q66061429-C9D38DD1-8476-4DBF-9A69-AF73E98B750F @default.
- Q66061429 P1132 Q66061429-DF16E2C9-F521-4D7A-BD8D-A81D90ABCE6E @default.
- Q66061429 P1476 Q66061429-1C09D6FC-7173-4905-A9FB-A16CD5B38AAD @default.
- Q66061429 P2899 Q66061429-CDE62996-EBBA-4811-A5F3-62C1BCC0A16B @default.
- Q66061429 P3098 Q66061429-76F89D46-D15E-41E3-9650-BEF647579DD3 @default.
- Q66061429 P31 Q66061429-4F17B72C-3E96-4C61-B468-9C6EA7D055B4 @default.
- Q66061429 P4135 Q66061429-F09E77E9-9034-48E7-BABE-266E09AC64EB @default.
- Q66061429 P4844 Q66061429-7CCF6C61-B8E3-48CD-A67C-47F4944154BE @default.
- Q66061429 P580 Q66061429-FE32F8D2-128C-4F75-B045-DB582A7D8F15 @default.
- Q66061429 P582 Q66061429-143FFE9A-5F72-47A4-8E8B-F4AA839BB398 @default.
- Q66061429 P6099 Q66061429-47BC443B-56B6-4689-9C03-3F7505B70B3D @default.
- Q66061429 P8363 Q66061429-D1BBD24D-8CBE-4092-8259-AAEF8538AC5C @default.
- Q66061429 P1050 Q12156 @default.
- Q66061429 P1132 "+75" @default.
- Q66061429 P1476 "A Pilot, Double-blind, Randomized, Parallel-group, Placebo-controlled, Exploratory Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria" @default.
- Q66061429 P2899 "+18" @default.
- Q66061429 P3098 "NCT04020653" @default.
- Q66061429 P31 Q30612 @default.
- Q66061429 P4135 "+60" @default.
- Q66061429 P4844 Q904464 @default.
- Q66061429 P580 "2019-09-06T00:00:00Z" @default.
- Q66061429 P582 "2020-05-31T00:00:00Z" @default.
- Q66061429 P6099 Q42824440 @default.
- Q66061429 P8363 Q78089383 @default.